摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,1'S,3S)-3-carboxy-1-(1',2'-dihydroxyethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

中文名称
——
中文别名
——
英文名称
(1R,1'S,3S)-3-carboxy-1-(1',2'-dihydroxyethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
英文别名
(1R,3S)-1-[(1S)-1,2-dihydroxyethyl]-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(1R,1'S,3S)-3-carboxy-1-(1',2'-dihydroxyethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline化学式
CAS
——
化学式
C12H15NO6
mdl
——
分子量
269.254
InChiKey
DCJLAZTZJRNILL-WHGOUJPWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3.3
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    130
  • 氢给体数:
    6
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    D-(+)-甘油醛左旋多巴 以 phosphate buffer 为溶剂, 反应 3.0h, 以600 mg的产率得到(1R,1'S,3S)-3-carboxy-1-(1',2'-dihydroxyethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
    参考文献:
    名称:
    Pictet–Spengler condensation of the antiparkinsonian drug l-DOPA with d-glyceraldehyde. Opposite kinetic effects of Fe3+ and Cu2+ ions and possible implications for the origin of therapeutic side effects
    摘要:
    In 0.05 M phosphate buffer, pH 7.4. and at 37 degreesC, L-DOPA. a widely used antiparkinsonian drug, reacted smoothly with D-glyceraldehyde to afford diastereoisomeric (1R,1 'S,3S)-3-carboxy-1-( 1 ' .2 ' -dihydroxyethyl)-6,7-dihydroxy- 1,1,3,4-tetrahydroisoquinoline (1) and (1S,1 'S,3S)-3-carboxy-1-( 1 ' ,2 ' -dihydroxyethyl)-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline (2) in an approx. 3:2 ratio. The prevalent formation of 1 over 2 reflects stereoselective cyclisation of a transient Schiff base in accord with the Felkin-Anh model. Fe3+ ions, present at relatively high levels in parkinsonian brains, markedly accelerated formation of 1 and 2. whereas Cu2+ decreased the reaction rate, due apparently to different sites of chelate formation between L-DOPA and the metal ions. Both metal ions markedly decreased the stereoselectivity of the reaction. Product 1 exhibited chelating properties toward metal ions comparable or stronger than those of L-DOPA. These results throw new light on the effects of transition metal ions on the Pictet-Spengler reaction and suggest a possible role of tetrahydroisoquinoline products from L-DOPA and carbohydrate metabolites in the severe side effects of the drug. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00309-6
点击查看最新优质反应信息

文献信息

  • Pictet–Spengler condensation of the antiparkinsonian drug l-DOPA with d-glyceraldehyde. Opposite kinetic effects of Fe3+ and Cu2+ ions and possible implications for the origin of therapeutic side effects
    作者:Paola Manini、Marco d'Ischia、Giuseppe Prota
    DOI:10.1016/s0968-0896(00)00309-6
    日期:2001.4
    In 0.05 M phosphate buffer, pH 7.4. and at 37 degreesC, L-DOPA. a widely used antiparkinsonian drug, reacted smoothly with D-glyceraldehyde to afford diastereoisomeric (1R,1 'S,3S)-3-carboxy-1-( 1 ' .2 ' -dihydroxyethyl)-6,7-dihydroxy- 1,1,3,4-tetrahydroisoquinoline (1) and (1S,1 'S,3S)-3-carboxy-1-( 1 ' ,2 ' -dihydroxyethyl)-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline (2) in an approx. 3:2 ratio. The prevalent formation of 1 over 2 reflects stereoselective cyclisation of a transient Schiff base in accord with the Felkin-Anh model. Fe3+ ions, present at relatively high levels in parkinsonian brains, markedly accelerated formation of 1 and 2. whereas Cu2+ decreased the reaction rate, due apparently to different sites of chelate formation between L-DOPA and the metal ions. Both metal ions markedly decreased the stereoselectivity of the reaction. Product 1 exhibited chelating properties toward metal ions comparable or stronger than those of L-DOPA. These results throw new light on the effects of transition metal ions on the Pictet-Spengler reaction and suggest a possible role of tetrahydroisoquinoline products from L-DOPA and carbohydrate metabolites in the severe side effects of the drug. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多